28153230|t|Spectrum-based and color-selective electrochemiluminescence immunoassay for determining human prostate specific antigen in near-infrared region
28153230|a|The conventional electrochemiluminescence (ECL) analyses were performed via detecting the time (or potential) dependent ECL intensity with the proceeding of ECL reaction. Herein, by spectrally recording all the photons generated in ECL process, a spectral ECL immunoassay was developed in near-infrared (NIR) region with human prostate specific antigen (PSA) as target and dual-stabilizers-capped CdTe nanocrystals (NCs) as tags. The CdTe NCs displayed efficient ECL around 780nm with the full width at half-maximum around 70nm in the immune-complexes, the maximum intensity on ECL spectrum profiles increased linearly with the logarithmic increased concentration of PSA from 20.0fg/mL to 100.0pg/mL, indicating a sensitive and color-selective ECL immunoassay in NIR region with improved anti-interference performance to biological autofluorescence and tissue absorption. The spectral ECL immunoassay in NIR region might provide an important technique support for developing color-selective ECL assay of different wavebands.
28153230	0	71	Spectrum-based and color-selective electrochemiluminescence immunoassay	T059	C3830325
28153230	88	93	human	T016	C0086418
28153230	94	119	prostate specific antigen	T116,T126,T129	C0138741
28153230	123	143	near-infrared region	T082	C0205147
28153230	148	160	conventional	T080	C0439858
28153230	161	185	electrochemiluminescence	T059	C3830326
28153230	187	190	ECL	T059	C3830326
28153230	192	200	analyses	T062	C0936012
28153230	234	238	time	T079	C0040223
28153230	243	252	potential	T080	C3245505
28153230	254	263	dependent	T080	C0851827
28153230	264	267	ECL	T059	C3830326
28153230	268	277	intensity	T080	C0522510
28153230	301	304	ECL	T059	C3830326
28153230	305	313	reaction	T169	C0443286
28153230	355	362	photons	T167	C0086805
28153230	376	379	ECL	T059	C3830326
28153230	380	387	process	T067	C1522240
28153230	391	415	spectral ECL immunoassay	T059	C3830325
28153230	433	459	near-infrared (NIR) region	T082	C0205147
28153230	465	470	human	T016	C0086418
28153230	471	496	prostate specific antigen	T116,T126,T129	C0138741
28153230	498	501	PSA	T116,T126,T129	C0138741
28153230	506	512	target	T169	C1521840
28153230	517	545	dual-stabilizers-capped CdTe	T130,T131,T197	C0054418
28153230	546	558	nanocrystals	T073	C1721058
28153230	560	563	NCs	T073	C1721058
28153230	568	572	tags	T074	C1139855
28153230	578	582	CdTe	T130,T131,T197	C0054418
28153230	583	586	NCs	T073	C1721058
28153230	607	610	ECL	T059	C3830326
28153230	633	659	full width at half-maximum	T081	C2986756
28153230	679	695	immune-complexes	T116,T129	C0003313
28153230	701	708	maximum	T081	C0806909
28153230	709	718	intensity	T080	C0522510
28153230	722	725	ECL	T059	C3830326
28153230	726	734	spectrum	T077	C2827424
28153230	735	743	profiles	T059	C1979963
28153230	744	753	increased	T081	C0205217
28153230	772	807	logarithmic increased concentration	T081	C2359145
28153230	811	814	PSA	T116,T126,T129	C0138741
28153230	872	903	color-selective ECL immunoassay	T059	C3830325
28153230	907	917	NIR region	T082	C0205147
28153230	932	961	anti-interference performance	T052	C1882330
28153230	965	975	biological	T080	C0205460
28153230	976	992	autofluorescence	T059	C0544711
28153230	997	1003	tissue	T024	C0040300
28153230	1004	1014	absorption	T067	C2347023
28153230	1020	1044	spectral ECL immunoassay	T059	C3830325
28153230	1048	1058	NIR region	T082	C0205147
28153230	1119	1144	color-selective ECL assay	T059	C3830325
28153230	1158	1167	wavebands	T081	C0449819